Ann: CE, FDA and CFDA Approval - Guangzhou Production Facility, page-367

The paperwork has been done as was anticipated. The China production facility is cleared for production. I thought this had been noted pretty clearly already and was unnecessary for an ASX announcement as it was just a formality and not material news.

In terms of production, well you don't just turn on an assembly line like this with a button. It needs to be fully staffed, input materials need to be ordered and on site, lots of logistics so i don't assume that full production will commence until the new year (which is only in a few short weeks mind you).

I'm sure Yacov would be wanting orders to start being filled asap as he has more riding on this than any of us. About $20M worth of Class B Performance rights hang in the balance if he doesn't quite make his revenue targets. If he does that will put us on a revenue un rate of about $70-80M p.a. in which case he might just about hit his Class C performance rights at the same time!